2018 BIO International Convention

4-7 June, 2018

Boston, USA

“The BIO International Convention is hosted by the Biotechnology Innovation Organization, which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products”.

Read more »

Meet2Win 2018 – Oncology Business Convention

17-18 May, 2018

Bordeaux, France

“MATWIN organises in Bordeaux on May 17th and 18th 2018 the 4th edition of its European Business Convention entirely dedicated to open innovation, collaborative research and technology transfer: MEET2WIN.

Organized around one-to-one meetings and bringing together all the parties involved in oncology innovation, MEET2WIN offers the opportunity to meet representatives of big pharma companies, biotechs, start-up, project leaders researchers, clinicians, TTO’s, investors etc. to increase R&D private/public partnerships”.

Read more »

Genesis Drug Discovery 2018

10 – 11 May, 2018

Barcelona, Spain

“Genesis Drug Discovery (GDD) brings the most innovative event that aims to provide an open and stimulating scientific and cultural exchange that will give all the participants the opportunity to share their experiences, foster collaborations across industry and academia and evaluate emerging technologies across the globe.

Genesis Drug Discovery (GDD) provides a platform to promote international exchanges for drug discovery, and to accelerate the cooperation for new drug research and development in the global market.

Read more »

EASL International Liver Congress 2018

April 11-15, 2018

Paris, France

ENYO Pharma is proud to announce that its Poster has been selected to be presented at EASL International Liver Congress in Paris on April 11-15th. The company team will present its latest Hepatitis B studies and data about its EYP001 compound (FXR agonist) developed for chronic hepatitis B patients. The annual Congress, which aim at presenting the latest topics in liver research, will be a great opportunity for the company as more than 10,000 delegates and 250 media representatives from all over the world will participate.

Read more »

J.P. Morgan 36th Annual Healthcare Conference

January 8-11, 2018

San Francisco, CA, California

“ENYO Pharma team will be at San Francisco during the J.P. Morgan conference, hosting the largest and most informative healthcare investment symposium in the industry. In 2018, more than 400 companies are expected, both public and private, to deliver presentations to more than 8,000 attendees.” (

Read more »